These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Malignant transformation during immunosuppressive therapy (azathioprine) of rheumatoid arthritis and systemic lupus erythematosus. A retrospective study. Wessel G; Abendroth K; Wisheit M Scand J Rheumatol Suppl; 1987; 67():73-5. PubMed ID: 3483077 [No Abstract] [Full Text] [Related]
4. Azathioprine in connective tissue disorders. Br Med J; 1972 Mar; 1(5801):645-6. PubMed ID: 5015288 [No Abstract] [Full Text] [Related]
5. Does long term treatment with azathioprine predispose to malignancy and death in patients with systemic lupus erythematosus? Nero P; Rahman A; Isenberg DA Ann Rheum Dis; 2004 Mar; 63(3):325-6. PubMed ID: 14962972 [No Abstract] [Full Text] [Related]
6. Efficacy of immunosuppressive drugs in rheumatic diseases. Steinberg AD Arthritis Rheum; 1973; 16(1):92-6. PubMed ID: 4540291 [No Abstract] [Full Text] [Related]
7. [Azathioprine in rheumatology]. Mathies H Fortschr Med; 1979 Dec; 97(48):2215-7. PubMed ID: 43824 [TBL] [Abstract][Full Text] [Related]
8. Preliminary results of azathioprine therapy in severe rheumatic disease. Swannell AJ; Coomes EN; Matthias JQ Ann Rheum Dis; 1970 Mar; 29(2):192-3. PubMed ID: 5427420 [No Abstract] [Full Text] [Related]
9. [Research on the effects of azathioprine (Imuran) in rheumatoid arthritis and lupic diseases]. Bruckner I; Stroescu O; Stroescu V; Gheorghiu M; Suţeanu S; Ghelerter L; Grozea P; Bârnaş M Med Interna (Bucur); 1969 May; 21(5):583-92. PubMed ID: 5344550 [No Abstract] [Full Text] [Related]
10. [Experience with treatment of rheumatic diseases with immunossuppressive substances]. Mathies H Z Rheumaforsch; 1969; 28(1):7-11. PubMed ID: 5810415 [No Abstract] [Full Text] [Related]
12. The recognition of drug effects. Decker JL Arthritis Rheum; 1972; 15(2):187-8. PubMed ID: 4554892 [No Abstract] [Full Text] [Related]
13. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus. Fox DA; McCune WJ Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180 [No Abstract] [Full Text] [Related]
14. [Therapy of rheumatoid arthritis with azathioprine--results of an open long-term study of at least 4 years with 528 patients]. Keysser M Z Rheumatol; 1993; 52(3):133-7. PubMed ID: 8368016 [TBL] [Abstract][Full Text] [Related]
15. Reticulum cell sarcoma in azathioprine-treated systemic lupus erythematosus. Hehir ME; Sewell JR; Hughes GR Ann Rheum Dis; 1979 Feb; 38(1):94-5. PubMed ID: 373652 [TBL] [Abstract][Full Text] [Related]
16. Azathioprine. Ahmed AR; Moy R Int J Dermatol; 1981 Sep; 20(7):461-7. PubMed ID: 7026466 [No Abstract] [Full Text] [Related]
17. [Long-term studies on indomethacin in rheumatology with special reference to its use in combination with azathioprine]. Klein G Arzneimittelforschung; 1971 Nov; 21(11):1828-30. PubMed ID: 5171814 [No Abstract] [Full Text] [Related]
18. Preliminary results of azathioprine treatment in severe rheumatic disease. Swannell AJ; Coomes EN Ann Phys Med; 1969 Aug; 10(3):112-20. PubMed ID: 4314025 [No Abstract] [Full Text] [Related]
19. Treatment of rheumatoid arthritis with immunosuppressive drugs. I. Clinical study. Moens C; Brocteur J Acta Rheumatol Scand; 1965; 11(3):212-20. PubMed ID: 4158235 [No Abstract] [Full Text] [Related]
20. Acute leukemia after azathioprine treatment of connective tissue disease. Alexson E; Brandt KD Am J Med Sci; 1977; 273(3):335-40. PubMed ID: 266841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]